# Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke

Study · id `cardio:ct-nct01270867` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01270867](<https://clinicaltrials.gov/study/NCT01270867>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01270867

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 178 participants.

## Technical summary

Registry record NCT01270867. Randomized; no masking; primary purpose treatment. Start 2011-02 (registry gives no type); primary completion 2011-12 (actual). Results posted on 2014-02-27.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 178 participants (enrolled count; ClinicalTrials.gov record NCT01270867, source copy `cardio:ctgov-nct01270867-2015-08-03`, retrieved 2026-10-26)
- Start date: 2011-02 (registry gives no type) (ClinicalTrials.gov record NCT01270867, source copy `cardio:ctgov-nct01270867-2015-08-03`, retrieved 2026-10-26)
- Primary completion: 2011-12 (actual) (ClinicalTrials.gov record NCT01270867, source copy `cardio:ctgov-nct01270867-2015-08-03`, retrieved 2026-10-26)
- Completion: 2012-03 (actual) (ClinicalTrials.gov record NCT01270867, source copy `cardio:ctgov-nct01270867-2015-08-03`, retrieved 2026-10-26)
- Results first posted: 2014-02-27 (ClinicalTrials.gov record NCT01270867, source copy `cardio:ctgov-nct01270867-2015-08-03`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01270867, source copy `cardio:ctgov-nct01270867-2015-08-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01270867-2015-08-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Randomized Trial Evaluating Performance of the Trevo Retriever Versus the Merci Retriever in Acute Ischemic Stroke
- Acronym: TREVO2
- Condition: Ischemic Stroke
- Intervention (Device): Mechanical Thrombectomy
- Lead sponsor: Stryker Neurovascular
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Stryker Neurovascular (`cardio:org-stryker-neurovascular`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial (`cardio:pubmed-22932714`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Periprocedural heparin use in acute ischemic stroke endovascular therapy: the TREVO 2 trial (`cardio:pubmed-29089415`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 4a33ba69960fc2e3c1c861ddcc66a868da69767e8b0341f875c01a468a50bc86
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
